Amneal Pharmaceuticals (AMRX) News Today $7.17 -0.04 (-0.55%) Closing price 04:00 PM EasternExtended Trading$7.18 +0.00 (+0.07%) As of 07:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Is Amneal Pharmaceuticals, Inc. (AMRX) the Best Pharma Stock to Buy for Long Term Growth?April 15 at 3:16 PM | insidermonkey.comMartingale Asset Management L P Has $1.19 Million Stock Position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Martingale Asset Management L P increased its stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 56.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 149,648 shares of the company's stock afterApril 14 at 5:29 AM | marketbeat.comExodusPoint Capital Management LP Makes New Investment in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)ExodusPoint Capital Management LP purchased a new position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 108,267 shares of the company's stock, valued at aApril 13 at 4:47 AM | marketbeat.comAmneal Donates $1.5 Million to Support Patients During Parkinson’s Awareness MonthApril 11, 2025 | finance.yahoo.comVanguard Group Inc. Grows Stock Holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Vanguard Group Inc. boosted its holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 1.5% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 14,841,969 shares of the company's stock after buying an additional 218,025 sharesApril 10, 2025 | marketbeat.comTrexquant Investment LP Has $3.67 Million Stock Holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Trexquant Investment LP increased its position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 93.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 462,720 shares of the company's stockApril 8, 2025 | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Shares Sold by Arrowstreet Capital Limited PartnershipArrowstreet Capital Limited Partnership reduced its holdings in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 25.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,541,058 shares of thApril 7, 2025 | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Shares Bought by Sei Investments Co.Sei Investments Co. lifted its stake in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 14.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 339,461 shares of the company's stock aApril 6, 2025 | marketbeat.comAmneal Announces Expanded Coverage for CREXONT® (Carbidopa and Levodopa) to Enhance Access for Parkinson’s Disease Patients in the U.S.April 3, 2025 | finance.yahoo.comAmneal gets expanded insurance coverage for its Parkinson’s disease treatmentApril 3, 2025 | msn.comAmneal Pharmaceuticals announces expanded coverage for CrexontApril 3, 2025 | markets.businessinsider.comDiametric Capital LP Makes New $252,000 Investment in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Diametric Capital LP purchased a new stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 31,782 shares of the company's stock, valued at approximaApril 3, 2025 | marketbeat.comAmneal Pharmaceuticals announces U.S. launch of BoruzuApril 2, 2025 | markets.businessinsider.comAmneal Pharmaceuticals (NASDAQ:AMRX) Trading Up 3.6% - Time to Buy?Amneal Pharmaceuticals (NASDAQ:AMRX) Shares Up 3.6% - Should You Buy?April 1, 2025 | marketbeat.comAmneal Launches BORUZU™, First Ready-to-Use Bortezomib Injection for Multiple Myeloma and Mantle Cell LymphomaApril 1, 2025 | finance.yahoo.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Shares Purchased by Prudential Financial Inc.Prudential Financial Inc. boosted its stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 29.6% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,183,781 shares of the company's stock after buying an addiMarch 31, 2025 | marketbeat.comRaymond James Financial Inc. Invests $2.95 Million in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Raymond James Financial Inc. acquired a new position in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 371,996 shares of the company'sMarch 30, 2025 | marketbeat.comSwiss National Bank Buys 31,900 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Swiss National Bank lifted its position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 13.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 274,000 shares of the company's stock after acquiring anMarch 28, 2025 | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Consensus Rating of "Buy" from AnalystsAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) has received an average rating of "Buy" from the five ratings firms that are covering the stock, Marketbeat.com reports. Five equities research analysts have rated the stock with a buy recommendation. The average 12-month target price amMarch 25, 2025 | marketbeat.comMagnetar Financial LLC Buys Shares of 47,804 Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Magnetar Financial LLC bought a new stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 47,804 shares of the company's stock, valued at approximateMarch 24, 2025 | marketbeat.comIntech Investment Management LLC Has $642,000 Holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Intech Investment Management LLC raised its position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 120.0% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 81,055 shares of the company's stock after purchasing an additional 44,208 shares duMarch 24, 2025 | marketbeat.com31,764 Shares in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Acquired by AmundiAmundi acquired a new position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 31,764 shares of the company's stock, valued at approximately $256,000. Other instituMarch 22, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Has $12.20 Million Stock Holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Charles Schwab Investment Management Inc. lifted its stake in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 9.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 1,539,934 shares of the company's stock after buying an addMarch 22, 2025 | marketbeat.comAmneal Pharmaceuticals (AMRX) Gets a Buy from Piper SandlerMarch 21, 2025 | markets.businessinsider.comAmneal Pharmaceuticals: Shares Still Feel Significantly UndervaluedMarch 19, 2025 | seekingalpha.comVictory Capital Management Inc. Boosts Stock Position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Victory Capital Management Inc. increased its stake in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 112.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 211,130 shMarch 19, 2025 | marketbeat.comAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Major Shareholder Tushar Bhikhubhai Patel Sells 5,000,000 SharesAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) major shareholder Tushar Bhikhubhai Patel sold 5,000,000 shares of the company's stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $8.35, for a total transaction of $41,750,000.00. Following the completion of the sale, the insider now directly owns 48,578,209 shares in the company, valued at $405,628,045.15. This represents a 9.33 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Large shareholders that own 10% or more of a company's shares are required to disclose their sales and purchases with the SEC.March 18, 2025 | marketbeat.comTushar Bhikhubhai Patel Sells 5,000,000 Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) StockMarch 18, 2025 | insidertrades.comAmneal Pharmaceuticals (AMRX) Stock Soars 45% on Success of New Parkinson’s TreatmentMarch 17, 2025 | markets.businessinsider.comAmneal Pharmaceuticals’ SWOT analysis: generic drug maker’s stock poised for growthMarch 14, 2025 | investing.comAmneal to Participate at Upcoming Investor ConferenceMarch 10, 2025 | businesswire.comAlphaQuest LLC Boosts Holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)AlphaQuest LLC grew its holdings in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 1,462.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 157,623 shares of the company's stock after acquiring an additionalMarch 10, 2025 | marketbeat.comInsider Selling: Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Director Sells 80,000 Shares of StockAmneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) Director Gautam Patel sold 80,000 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $8.90, for a total value of $712,000.00. Following the sale, the director now owns 1,808,886 shares in the company, valued at $16,099,085.40. The trade was a 4.24 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.March 6, 2025 | marketbeat.comAmneal Pharmaceuticals BLA submissions for denosumab biosimilars accepted by FDAMarch 4, 2025 | markets.businessinsider.comHandelsbanken Fonder AB Acquires Shares of 39,000 Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)Handelsbanken Fonder AB acquired a new stake in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 39,000 shares of the company's stock, valMarch 4, 2025 | marketbeat.comAmneal's BLA Submissions for Two Denosumab Biosimilars Accepted for Review by U.S. FDAMarch 3, 2025 | businesswire.comAmneal Pharmaceuticals price target raised to $11 from $10 at BarclaysMarch 3, 2025 | markets.businessinsider.comAmneal Pharmaceuticals (NASDAQ:AMRX) Price Target Raised to $11.00Barclays boosted their price target on shares of Amneal Pharmaceuticals from $10.00 to $11.00 and gave the company an "overweight" rating in a research report on Monday.March 3, 2025 | marketbeat.comNew York State Common Retirement Fund Boosts Stock Position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)New York State Common Retirement Fund boosted its position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 24.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 220,627 shares of the company's stock after purchasingMarch 3, 2025 | marketbeat.comAmneal Pharmaceuticals (NASDAQ:AMRX) Releases Earnings Results, Misses Expectations By $0.03 EPSAmneal Pharmaceuticals (NASDAQ:AMRX - Get Free Report) issued its quarterly earnings data on Friday. The company reported $0.12 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.15 by ($0.03). The business had revenue of $730.52 million during the quarter, compared to the consensus estimate of $708.21 million. Amneal Pharmaceuticals had a negative net margin of 6.88% and a negative return on equity of 346.26%. During the same quarter last year, the business earned $0.14 EPS.March 2, 2025 | marketbeat.comAmneal Pharmaceuticals Full Year 2024 Earnings: EPS Misses ExpectationsMarch 1, 2025 | uk.finance.yahoo.comIs Amneal Pharmaceuticals, Inc. (AMRX) the Best Weight Loss Drug Stock to Buy According to Analysts?March 1, 2025 | insidermonkey.comIs Amneal Pharmaceuticals, Inc. (AMRX) the Best Weight Loss Drug Stock to Buy According to Analysts?March 1, 2025 | finance.yahoo.comAmneal Pharmaceuticals, Inc. (NYSE:AMRX) Q4 2024 Earnings Call TranscriptMarch 1, 2025 | insidermonkey.comAmneal Pharmaceuticals (NASDAQ:AMRX) Updates FY 2025 Earnings GuidanceAmneal Pharmaceuticals (NASDAQ:AMRX) updated its FY 2025 earnings guidance. The company provided EPS guidance of 0.650-0.700 for the period, compared to the consensus estimate of 0.710. The company also issued revenue guidance of $3.0 billionillion-$3.1 billionillion, compared to the consensus estimate of $2.9 billionillion.March 1, 2025 | marketbeat.comAmneal Pharmaceuticals, Inc. (AMRX) Q4 2024 Earnings Call TranscriptFebruary 28, 2025 | seekingalpha.comAmneal Pharmaceuticals, Inc. 2024 Q4 - Results - Earnings Call PresentationFebruary 28, 2025 | seekingalpha.comAmneal Pharmaceuticals reports Q4 adjusted EPS 12c, consensus 15cFebruary 28, 2025 | markets.businessinsider.comAmneal Pharmaceuticals sees FY25 adjusted EPS 65c-75c, consensus 71cFebruary 28, 2025 | markets.businessinsider.comAmneal’s (NASDAQ:AMRX) Q4 Sales Beat Estimates, Guides for Strong Full-Year SalesFebruary 28, 2025 | msn.com Remove Ads Get Amneal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMRX and its competitors with MarketBeat's FREE daily newsletter. Email Address AMRX Media Mentions By Week AMRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMRX News Sentiment▼1.080.80▲Average Medical News Sentiment AMRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMRX Articles This Week▼75▲AMRX Articles Average Week Remove Ads Get Amneal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AMRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ASND News Today ROIV News Today LNTH News Today TGTX News Today RVMD News Today BBIO News Today LEGN News Today BPMC News Today SRPT News Today TLX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMRX) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amneal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amneal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AMRX Stock Free AMRX Stock Alerts